Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Proto Labs (NYSE:PRLB - Get Rating) updated its third quarter 2022 earnings guidance on Monday. The company provided EPS guidance of $0.36-$0.44 for the period. The company issued revenue guidance of $121.00 million-$129.00 million, compared to the consensus revenue estimate of $133.27 million. Wall Street Analyst Weigh In

A number of brokerages recently issued reports on PRLB. StockNews.com upgraded shares of Proto Labs from a hold rating to a buy rating in a research report on Monday, August 8th. Craig Hallum lowered their price objective on shares of Proto Labs to $42.00 in a research report on Tuesday, August 9th.Proto Labs Trading Down 0.7 %

PRLB opened at $46.43 on Monday. The stock has a market capitalization of $1.28 billion, a PE ratio of 52.76 and a beta of 1.28. Proto Labs has a 1-year low of $39.36 and a 1-year high of $81.20. The firm has a 50-day moving average price of $47.57 and a two-hundred day moving average price of $49.03.

Proto Labs (NYSE:PRLB - Get Rating) last issued its earnings results on Friday, August 5th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.07. The company had revenue of $126.90 million for the quarter, compared to analyst estimates of $127.28 million. Proto Labs had a net margin of 4.88% and a return on equity of 2.95%. The company's revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.47 EPS. On average, research analysts predict that Proto Labs will post 0.79 EPS for the current year. Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of PRLB. UBS Group AG boosted its stake in Proto Labs by 9.9% during the 2nd quarter. UBS Group AG now owns 2,378 shares of the industrial products company's stock worth $114,000 after acquiring an additional 215 shares during the last quarter. Graham Capital Management L.P. boosted its stake in Proto Labs by 8.6% during the 1st quarter. Graham Capital Management L.P. now owns 6,351 shares of the industrial products company's stock worth $335,000 after acquiring an additional 501 shares during the last quarter. Quantbot Technologies LP bought a new position in Proto Labs during the 2nd quarter worth approximately $30,000. Gabelli Funds LLC boosted its stake in Proto Labs by 17.2% during the 1st quarter. Gabelli Funds LLC now owns 16,759 shares of the industrial products company's stock worth $887,000 after acquiring an additional 2,459 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Proto Labs by 14.1% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 23,785 shares of the industrial products company's stock worth $1,258,000 after acquiring an additional 2,932 shares during the last quarter. Institutional investors own 93.35% of the company's stock. About Proto Labs (Get Rating)

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.Featured StoriesGet a free copy of the StockNews.com research report on Proto Labs (PRLB)Here is a Simple 4 Stock Portfolio that Can Outperform the MarketIs AMC Entertainment Pulling a Fast One on the APEs?Here’s How the Inflation Reduction Act Energizes Power Stock2 Important Retail Stock Battles to WatchMarketBeat: Week in Review 8/8 - 8/12

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

David McNatt discusses ESG investing and offers ways to avoid pitfalls and to understand exactly what kinds of companies you are buying.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.